title: Revisiting the role of antiandrogen strategies in ovarian cancer.
abstract: Androgen receptors are frequently expressed in epithelial ovarian cancer (EOC). Their role in the development of EOC is not fully understood. In the present review we first discuss the epidemiological data linking a hyperandrogen state to a higher risk for ovarian cancer, second describe in vitro studies of the role of androgens in influencing the growth of EOC, and finally review the completed clinical trials with compounds that exploit the androgen axis in patients with ovarian cancer. The therapeutic approaches that inhibit androgen signaling have so far produced only modest response rates. In the light of new data regarding the role of androgen stimulation in the evolution of EOC and the emergence of new compounds used for the treatment of other hormone-driven malignancies, such as prostate and breast cancer, we provide suggestions for new studies of antiandrogen therapeutics in the treatment of EOC. A specific example is the new agent abiraterone. In addition, we propose a panel of molecules that could be assessed as potential biomarkers that may aid patient selection for this approach in the future.
authors.affiliation: Royal Marsden Hospital and Institute of Cancer Research, Sutton, Surrey, UK.
authors.forename: Dionysis
authors.initials: D
authors.lastname: Papadatos-Pastos
authors.forename: Konstantin J
authors.initials: KJ
authors.lastname: Dedes
authors.forename: Johann S
authors.initials: JS
authors.lastname: de Bono
authors.forename: Stanley B
authors.initials: SB
authors.lastname: Kaye
mesh_terms: D000726:Androgen Antagonists / Q000627:therapeutic use*; D000728:Androgens / Q000378:metabolism; D000077216:Carcinoma, Ovarian Epithelial; D005260:Female; D006801:Humans; D009375:Neoplasms, Glandular and Epithelial / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology
chemical_list: D000726:Androgen Antagonists; D000728:Androgens